Researchers discovered that some cases of glioblastoma, the most common and aggressive form of primary brain cancer, are caused by the fusion of two adjacent genes. The study also found that drugs that target the protein produced by this genetic aberration can dramatically slow the growth of glioblastomas in mice.
A new synthetic peptide has the potential to deliver medications through the blood brain barrier.
Scientists have long believed that glioblastoma multiforme, the most aggressive type of primary brain tumor, begins in glial cells that make up supportive tissue in the brain or in neural stem cells. Researchers found that the tumors can originate from other types of differentiated cells in the nervous system, including cortical neurons.
A new study reveals how the physical force exerted by the solid components of brain tumors impacts surrounding tissue, resulting in apoptosis and neurological dysfunction. Researchers reports the drug lithium, commonly prescribed for bipolar disorder, can help reverse some of the damage caused by the solid stress of the tumor.
New findings could provide additional insight into the cause of glioblastoma and provide new options for personalized therapeutic treatments.
A new artificial intelligence convolutional neural network is 94.6% accurate at diagnosing real-time intraoperative brain tumors.
New research from the University of Wisconsin-Madison explains why the incurable brain cancer, glioblastoma multiforme (GBM), is highly resistant to...
When aggressive, malignant tumors appear in more than one location in the brain, patient survival tends to be significantly shorter than when the disease starts as a single tumor, even though patients in both groups undergo virtually identical treatments, according to research at Cedars-Sinai Medical Center's Maxine Dunitz Neurosurgical Research Institute.
Researchers believe their findings could lead to new targets for brain cancer therapies.
Researchers uncover a possible reason as to why astrocytomas don't respond to standard forms of cancer treatment.
Researchers have successfully replicated an entire, viable glioblastoma brain tumor via 3D bioprinting. The bioprinted tumor includes a complex system of blood vessel-like tubes through which blood cells and drug molecules can flow, simulating a real tumor.
A chimeric virus passes through the blood-bran barrier and destroys brain tumors in mice, a new study reports.